echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The Basic Health Care and Health Promotion Act is implemented

    The Basic Health Care and Health Promotion Act is implemented

    • Last Update: 2021-03-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Law of the People's Republic of China on Basic Health Care and Health Promotion was adopted by a vote at the 15th session of the Standing Committee of the 13th National People's Congress on December 28, 2019 and officially implemented on June 1.

    vigorously develop the cause ofArticle 7 The State shall vigorously develop the cause of Chinese medicine, adhere to the combination of Chinese and Western medicine, inheritance and innovation, and give full play to the unique role of Chinese medicine in the cause of health care and health.Article 66 The State shall strengthen the protection and development of Chinese medicine, fully reflect its characteristics and advantages, and give full play to its role in prevention, health care, medical treatment and rehabilitation.

    to improve drug supplyArticle 58 The State shall improve the system of safeguarding the supply of medicines and establish a coordination mechanism for the work to ensure the safety, effective and accessability of medicines.

    the implementation of the basic drugArticle 59 The State shall implement a system of essential drugs, select an appropriate number of basic drug varieties and meet the basic drug demand for disease prevention and treatment.The State publishes the list of essential drugs and adjusts the list of essential drugs dynamically according to the practice of clinical application of drugs, changes in drug standards, and the new market availability of medicines. Essential medicines are included in the list of essential medical insurance medicines as a matter of priority in accordance with the provisions. The State enhances the supply capacity of essential drugs, strengthens the supervision of the quality of essential drugs, and ensures that essential drugs are fairly accessable and reasonably used.

    to support drug development, productionArticle 60 The State shall establish and improve a system of drug examination and approval oriented towards clinical needs, and support the development and production of drugs in urgent need of drugs, medicines for children and drugs for the prevention and treatment of rare diseases and major diseases, so as to meet the needs of disease prevention and control.Article 61 The State shall establish and improve a system for the retrospective process of drug development, production, circulation and use, strengthen drug management and ensure the quality of medicines.

    strengthen drug price supervision andArticle 62 The State shall establish and improve a system for monitoring drug prices, conduct cost price investigations, strengthen drug price supervision and inspection, investigate and punish illegal acts such as price monopoly, price fraud and unfair competition in accordance with the law, and safeguard drug price order.The State strengthens the management and guidance of drug classification procurement. Bidders participating in drug procurement tenders shall not bid at quotations below cost, or by fraud, bid rigging, abuse of market dominance, etc.Article 63 The State shall establish medical reserves at the central and local levels to safeguard emergency needs such as major disasters, outbreaks and other emergencies.Article 64 The State shall establish and improve a monitoring system for drug supply and demand, collect and summarize and analyze information on drug supply and demand in a timely manner, and regularly publish information on the production, circulation and use of drugs.   Article 65 The State shall strengthen the management of medical devices, improve the standards and norms of medical devices, and raise the level of safety and effectiveness of medical devices.

    the implementation of a hierarchical diagnosis and treatment   Article 30 The State shall promote the implementation of a hierarchical diagnosis and treatment system for basic medical services, guide non-emergency patients to visit primary health care institutions first, implement the system of first consultation responsibility and the system of responsibility for referral examination, and gradually establish a mechanism for first consultation at the grass-roots level, two-way referral, rapid and slow division of treatment, up-and-down linkage, and link up with the basic medical insurance system. Local people's governments at or above the county level shall, in accordance with the medical and health needs of their administrative regions, integrate the medical and health resources organized by the regional governments and establish cooperative mechanisms for medical services such as medical complexes according to local conditions. Encourage medical and health institutions organized by social forces to participate in the cooperative mechanism of medical services.

    large hospitals focus on the diagnosis and treatment of difficult   Article 35 Primary medical and health institutions shall mainly provide basic medical and health services such as prevention, health care, health education and disease management, establish health records for residents, diagnosis and treatment of common and frequent diseases, as well as rehabilitation and care of some diseases, receive referrals from hospitals, and transfer patients beyond their capacity to serve to hospitals.   Hospitals mainly provide medical and health services such as diagnosis and treatment of diseases, especially acute and critical and difficult conditions, emergency medical treatment and rescue, and health education, and carry out medical education, training of medical and health personnel, medical scientific research and operational guidance to primary health care institutions.   Professional public health institutions mainly provide infectious diseases, chronic noncommunicable diseases, occupational diseases, endemic diseases and other diseases prevention and control and health education, maternal and child health care, mental health, pre-hospital first aid, blood supply, food safety risk monitoring and assessment, birth defect prevention and control and other public health services.   Article 36 All types of medical and health institutions at all levels shall divide and cooperate in order to provide citizens with all-round full-cycle medical and health services such as prevention, health care, treatment, nursing, rehabilitation and peaceful treatment. People's governments at all levels have taken measures to support medical and health institutions to establish cooperative mechanisms with institutions for the elderly, child welfare institutions and community organizations to provide safe and convenient medical and health services for the elderly and children with disabilities.

    support the development of medical institutions below the county level   Article 8 The State shall rationally plan and allocation medical and health resources, focus on the grass-roots level, and take various measures to give priority to supporting the development of medical and health institutions below the county level and improving their capacity for medical and health services.   Article 9 The State shall increase its financial investment in medical and health services and focus on supporting the development of medical and health undertakings in the old revolutionary areas, ethnic areas, frontier areas and economically underdeveloped areas by increasing transfer payments.   Article 29 Basic medical services are mainly provided by medical and health institutions organized by the Government. Encourage medical and health institutions organized by social forces to provide basic medical services.

    to establish a slow disease management   Article 22 The State shall establish a system for the prevention and control of chronic noncommunicable diseases, carry out monitoring, investigation and comprehensive prevention and control interventions on chronic noncommunicable diseases and their risk factors, identify high-risk groups in a timely manner, and provide services such as diagnosis and treatment, early intervention, follow-up management and health education to patients and high-risk groups. (Seber blue
    )
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.